CervoMed Inc. (CRVO) vs Grace Therapeutics, Inc. (GRCE)
A side-by-side comparison of CervoMed Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVO
CervoMed Inc.
$3.26HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
GRCE
Grace Therapeutics, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT
Total return — CRVO vs GRCE
growth of $100 · dividends reinvested · last 2yCRVO -76.9% (-52.0%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
CRVO GRCE
CRVO vs GRCE: by the numbers
- •GRCE is the larger company ($34M vs $30M market cap).
- •Both run net losses; GRCE's is the smaller (0.00% vs -9408.76% net margin).
Metrics side by side
Valuation
| Metric | CRVO | GRCE |
|---|---|---|
| P/S ratio | 93.57 | N/A |
| P/B ratio | 1.31 | 0.71 |
Profitability
| Metric | CRVO | GRCE |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -9408.76% | 0.00% |
| ROE | -132.18% | -44.50% |
| ROIC | -135.73% | -52.61% |
Growth (annualized)
| Metric | CRVO | GRCE |
|---|---|---|
| Total return CAGR (5Y) | -38.25% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.